Thanks Santalucía and AECC for your funding

On January 2019, we received Grupo Santalucía people in our lab and told them about the project thay have funded in collaboration with the Ascoación Española Contra el Cáncer (AECC). This project is part of one of our research lines focused on the study of a type of orphan cancers, the granulosa cell tumors of the ovary. It was a pleasure to explain all of them how we are using the technology CRISPR/Cas9 to better understand the role of the transcription factor FOXL2 in the development and progression of these rare cancers.